ACE and autosomal dominant polycystic kidney disease: Angiotensin converting enzyme inhibitors (ACEI)s and Angiotensin receptor blockers (ARBs) are the preferred medications used in the management of hypertension in ADPKD because they have been proven beneficial to: control cardiac dysfunction; decrease LVH and end organ damage; and reduce mortality[14].